Join
Live feed
·
PRReleasevia Quantisnow
Kazia Therapeutics Limited logo

POSITIVE DATA FOR PAXALISIB IN TWO CHILDHOOD BRAIN CANCERS PRESENTED AT 20TH ISPNO ANNUAL MEETING

ByQuantisnow·Wall Street's wire, on your screen.
KZIA· Kazia Therapeutics Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KZIA (Kazia Therapeutics Limited) and more on Quantisnow.